The Lancet Publishes Phase 3 Results Demonstrating Efficacy, Safety and Tolerability of SUBLOCADE(TM - PharmiWeb.com

Submitted by Anonymous (not verified) on Tue, 02/19/2019 - 13:17

The Lancet Publishes Phase 3 Results Demonstrating Efficacy, Safety and Tolerability of SUBLOCADE(TM  PharmiWeb.comSLOUGH, United Kingdom and RICHMOND, Va., Feb. 19, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that data from its pivotal phase 3 ...